SCHEMBL17346325

SCHEMBL17346325

CCN(C)CCCN(CCSCc1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
SIGMAR1 Q99720 4/20 0.40
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
CHRM2 P08172 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
CHRM1 P11229 1/20 0.37
DRD1 P21728 1/20 0.37
ADRA1A P35348 1/20 0.37
OPRM1 P35372 1/20 0.37
DRD3 P35462 1/20 0.37
KCNH2 Q12809 1/20 0.37
CYP2C19 P33261 2/20 0.36
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CNR2 P34972 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17346440 0.92 TSHR (0.44) TSHRSIGMAR1SLC6A2SLC6A4SLC6A3
SCHEMBL17346323 0.87 SIGMAR1 (0.44) TSHRSIGMAR1CYP2C19POLBTDP1
SCHEMBL17345907 0.87 SIGMAR1 (0.45) SIGMAR1SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL17346183 0.81 SIGMAR1 (0.44) TSHRSIGMAR1CYP2C19POLBTDP1
SCHEMBL17346426 0.81 TAAR1 (0.43) TSHRSIGMAR1SLC6A2SLC6A4SLC6A3
SCHEMBL17346348 0.81 BCHE (0.41) SIGMAR1SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL17346409 0.81 CYP2C19 (0.43) SIGMAR1SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL17345900 0.76 SIGMAR1 (0.47) SIGMAR1CYP2C19CYP1A2CYP3A4CYP2D6
SCHEMBL17346235 0.76 SIGMAR1 (0.46) SIGMAR1CHRM2ALDH1A1
SCHEMBL17345915 0.76 SIGMAR1 (0.43) SIGMAR1POLBTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN TSHR 4074/4885SIGMAR1 412/4885SLC6A2 749/4885
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN TSHR 4074/4885SIGMAR1 412/4885SLC6A2 749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.